Literature DB >> 14597634

Cytosolic peroxiredoxin attenuates the activation of Jnk and p38 but potentiates that of Erk in Hela cells stimulated with tumor necrosis factor-alpha.

Sang Won Kang1, Tong-Shin Chang, Tae-Hoon Lee, Eun Seon Kim, Dae-Yeul Yu, Sue Goo Rhee.   

Abstract

Tumor necrosis factor-alpha (TNF-alpha) induces the activation of all three types of mitogen-activated protein kinase (MAPK): c-Jun NH(2)-terminal kinase (JNK), p38, and extracellular signal-regulated kinase (ERK). This cytokine also induces the production of several types of reactive oxygen species, including H(2)O(2). With the use both of HeLa cells expressing wild-type or dominant negative forms of the cytosolic peroxidase peroxiredoxin II and of mouse embryonic fibroblasts deficient in this protein, we evaluated the roles of H(2)O(2) in the activation of MAPKs by TNF-alpha. In vitro kinase assays as well as immunoblot analysis with antibodies specific for activated MAPKs indicated that H(2)O(2) produced in response to TNF-alpha potentiates the activation of JNK and p38 induced by this cytokine but inhibits that of ERK. Our results also suggest that cytosolic peroxiredoxins are important regulators of TNF signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14597634     DOI: 10.1074/jbc.M307698200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage.

Authors:  Byoung-Joon Song; Kwan-Hoon Moon; Vijay V Upreti; Natalie D Eddington; Insong J Lee
Journal:  Curr Pharm Biotechnol       Date:  2010-08       Impact factor: 2.837

2.  Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors.

Authors:  Jaeyul Kwon; Seung-Rock Lee; Kap-Seok Yang; Younghee Ahn; Yeun Ju Kim; Earl R Stadtman; Sue Goo Rhee
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-08       Impact factor: 11.205

3.  Increased oxidative-modifications of cytosolic proteins in 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-exposed rat liver.

Authors:  Vijay V Upreti; Kwan-Hoon Moon; Li-Rong Yu; Insong J Lee; Natalie D Eddington; Xiaoying Ye; Timothy D Veenstra; Byoung-Joon Song
Journal:  Proteomics       Date:  2010-12-15       Impact factor: 3.984

Review 4.  The redox biology of schistosome parasites and applications for drug development.

Authors:  Hsin-Hung Huang; Coraline Rigouin; David L Williams
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes.

Authors:  Qiang Li; Maged M Harraz; Weihong Zhou; Liang N Zhang; Wei Ding; Yulong Zhang; Tim Eggleston; Charles Yeaman; Botond Banfi; John F Engelhardt
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

6.  Obovatol attenuates microglia-mediated neuroinflammation by modulating redox regulation.

Authors:  Jiyeon Ock; Hyung S Han; Su H Hong; So Y Lee; Young-Min Han; Byoung-Mog Kwon; Kyoungho Suk
Journal:  Br J Pharmacol       Date:  2010-04       Impact factor: 8.739

7.  Expression of peroxiredoxin 1 and 4 promotes human lung cancer malignancy.

Authors:  Hong Jiang; Lisha Wu; Murli Mishra; Hedy A Chawsheen; Qiou Wei
Journal:  Am J Cancer Res       Date:  2014-09-06       Impact factor: 6.166

Review 8.  Basic principles and emerging concepts in the redox control of transcription factors.

Authors:  Regina Brigelius-Flohé; Leopold Flohé
Journal:  Antioxid Redox Signal       Date:  2011-04-05       Impact factor: 8.401

9.  Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies.

Authors:  Qiou Wei; Hong Jiang; Connie P Matthews; Nancy H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-04       Impact factor: 11.205

10.  Trichostatin A enhances proliferation and migration of vascular smooth muscle cells by downregulating thioredoxin 1.

Authors:  Seungjeong Song; Sang Won Kang; Chulhee Choi
Journal:  Cardiovasc Res       Date:  2010-01-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.